COLUMBUS CIRCLE INVESTORS - INTRA CELLULAR THERAPIES INC ownership

INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 133 filers reported holding INTRA CELLULAR THERAPIES INC in Q2 2018. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
COLUMBUS CIRCLE INVESTORS ownership history of INTRA CELLULAR THERAPIES INC
ValueSharesWeighting
Q2 2019$6,927,000
+46.8%
533,636
+37.8%
0.18%
+54.2%
Q1 2019$4,718,000
-11.1%
387,391
-16.8%
0.12%
-20.0%
Q4 2018$5,306,000
-50.5%
465,844
-5.6%
0.15%
-29.9%
Q3 2018$10,711,000
+15.3%
493,608
-6.1%
0.21%
+11.5%
Q2 2018$9,286,000
-20.7%
525,502
-5.5%
0.19%
-19.3%
Q1 2018$11,707,000
+150.3%
556,156
+72.2%
0.24%
+167.4%
Q4 2017$4,678,000
+88.5%
323,049
+105.4%
0.09%
+111.9%
Q3 2017$2,482,000
-59.9%
157,305
-58.7%
0.04%
-51.7%
Q1 2017$6,190,000
-21.0%
380,911
-26.6%
0.09%
-14.7%
Q4 2016$7,833,000
+31.6%
519,108
+32.9%
0.10%
+59.4%
Q3 2016$5,954,000
-72.2%
390,650
-29.2%
0.06%
-70.2%
Q2 2016$21,433,000
+95.4%
552,104
+39.9%
0.22%
+119.4%
Q1 2016$10,970,000
-43.9%
394,606
+8.6%
0.10%
-37.6%
Q4 2015$19,551,000
+99.4%
363,471
+48.5%
0.16%
+96.2%
Q3 2015$9,803,000244,8420.08%
Other shareholders
INTRA CELLULAR THERAPIES INC shareholders Q2 2018
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 175,000$9,115,75010.70%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 317,856$16,547,5835.57%
Deep Track Capital, LP 2,600,000$135,434,0005.23%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,369,849$71,355,4343.86%
SILVERARC CAPITAL MANAGEMENT, LLC 208,730$10,872,7463.30%
DCF Advisers, LLC 107,157$5,581,8083.04%
Bellevue Group AG 3,170,250$165,138,3232.66%
Vahanian & Associates Financial Planning Inc. 15,217$792,6542.55%
Iron Triangle Partners LP 330,549$17,218,2972.52%
TANG CAPITAL MANAGEMENT LLC 300,000$15,627,0002.20%
View complete list of INTRA CELLULAR THERAPIES INC shareholders